The epilepsy bioinformatics study for anti-epileptogenic therapy (EpiBioS4Rx) clinical biomarker: Study design and protocol.


Journal

Neurobiology of disease
ISSN: 1095-953X
Titre abrégé: Neurobiol Dis
Pays: United States
ID NLM: 9500169

Informations de publication

Date de publication:
03 2019
Historique:
received: 13 04 2018
revised: 06 07 2018
accepted: 20 07 2018
pubmed: 27 7 2018
medline: 22 11 2019
entrez: 27 7 2018
Statut: ppublish

Résumé

The Epilepsy Bioinformatics Study for Anti-epileptogenic Therapy (EpiBioS4Rx) is a longitudinal prospective observational study funded by the National Institute of Health (NIH) to discover and validate observational biomarkers of epileptogenesis after traumatic brain injury (TBI). A multidisciplinary approach has been incorporated to investigate acute electrical, neuroanatomical, and blood biomarkers after TBI that may predict the development of post-traumatic epilepsy (PTE). We plan to enroll 300 moderate-severe TBI patients with a frontal and/or temporal lobe hemorrhagic contusion. Acute evaluation with blood, imaging and electroencephalographic monitoring will be performed and then patients will be tracked for 2 years to determine the incidence of PTE. Validation of selected biomarkers that are discovered in planned animal models will be a principal feature of this work. Specific hypotheses regarding the discovery of biomarkers have been set forth in this study. An international cohort of 13 centers spanning 2 continents will be developed to facilitate this study, and for future interventional studies.

Identifiants

pubmed: 30048805
pii: S0969-9961(18)30311-5
doi: 10.1016/j.nbd.2018.07.025
pmc: PMC6344322
mid: NIHMS1502235
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

110-114

Subventions

Organisme : NIBIB NIH HHS
ID : P41 EB015922
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA211015
Pays : United States
Organisme : NINDS NIH HHS
ID : U54 NS100064
Pays : United States

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Références

J Neurotrauma. 2013 Jul 15;30(14):1305-9
pubmed: 23469770
Arch Phys Med Rehabil. 2003 Mar;84(3):365-73
pubmed: 12638104
Neuropsychiatr Dis Treat. 2017 Aug 30;13:2301-2306
pubmed: 28919762
Neurology. 2013 Mar 12;80(11 Suppl 3):S2-6
pubmed: 23479538
Epilepsia. 2016 May;57(5):735-45
pubmed: 27012461
Epilepsia. 2014 Jul;55(7):1109-19
pubmed: 24754437
J Clin Epidemiol. 2010 Nov;63(11):1179-94
pubmed: 20685078
J Neurotrauma. 1998 Aug;15(8):573-85
pubmed: 9726257
Brain. 2016 Sep;139(Pt 9):2441-55
pubmed: 27497924
J Neurotrauma. 2012 Apr 10;29(6):1126-39
pubmed: 22220819
Epilepsia. 1999 May;40(5):584-9
pubmed: 10386527
Epilepsia. 2013 Jul;54(7):1240-50
pubmed: 23718645
N Engl J Med. 1998 Jan 1;338(1):20-4
pubmed: 9414327
J Surg Res. 2010 May 15;160(2):302-7
pubmed: 19345376
Neurology. 2010 Aug 31;75(9):792-8
pubmed: 20805525

Auteurs

Paul M Vespa (PM)

David Geffen School of Medicine at UCLA, United States. Electronic address: pvespa@mednet.ucla.edu.

Vikesh Shrestha (V)

David Geffen School of Medicine at UCLA, United States.

Nicholas Abend (N)

University of Pennsylvania, United States.

Denes Agoston (D)

Uniformed Services University, United States.

Alicia Au (A)

University of Pittsburgh, United States.

Michael J Bell (MJ)

Children's National Health System, United States.

Thomas P Bleck (TP)

Rush University, United States.

Manuel Buitrago Blanco (MB)

David Geffen School of Medicine at UCLA, United States.

Jan Claassen (J)

Columbia University, United States.

Ramon Diaz-Arrastia (R)

University of Pennsylvania, United States.

Dominique Duncan (D)

University of Southern California, United States.

Ben Ellingson (B)

David Geffen School of Medicine at UCLA, United States.

Brandon Foreman (B)

University of Cincinnati, United States.

Emily J Gilmore (EJ)

Yale University, United States.

Lawrence Hirsch (L)

Yale University, United States.

Martin Hunn (M)

The Alfred Hospital Melbourne, Australia.

Alaa Kamnaksh (A)

Uniformed Services University, United States.

David McArthur (D)

David Geffen School of Medicine at UCLA, United States.

Andrew Morokoff (A)

Royal Melbourne Hospital, United States.

Terrence O'Brien (T)

Royal Melbourne Hospital, United States.

Kristine O'Phelan (K)

University of Miami, United States.

Courtney L Robertson (CL)

Johns Hopkins University, United States.

Eric Rosenthal (E)

Harvard University/Massachusetts General Hospital, United States.

Richard Staba (R)

David Geffen School of Medicine at UCLA, United States.

Arthur Toga (A)

University of Southern California, United States.

Frederick A Willyerd (FA)

Phoenix Children's Hospital, United States.

Lara Zimmermann (L)

University of California, Davis, United States.

Elisa Yam (E)

David Geffen School of Medicine at UCLA, United States.

Susana Martinez (S)

David Geffen School of Medicine at UCLA, United States.

Courtney Real (C)

David Geffen School of Medicine at UCLA, United States.

Jerome Engel (J)

David Geffen School of Medicine at UCLA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH